The study is the first, to the researchers’ knowledge, to evaluate both survival and cost metrics across non-small cell lung ...

As immunotherapy becomes a cornerstone of cancer treatment, some of the top U.S. cancer centers and health systems are accelerating research efforts to identify the biological mechanisms behind ...

I rebuilt my life after breast cancer—finding love, moving states, and embracing joy. Then, everything turned upside down.

Deadly pancreatic cancer usually has no symptoms until its advanced stages. Gary Larkin remembers the exact moment he first ...

CAR-T cells are specialized immune cells genetically modified to recognize and attack cancer cells. Researchers at Nagoya University in Japan and ...

ASCO Data Shows New Therapy Extends Survival in Small Cell Lung Cancer. Here's what you need to know about the new ...

What to know about new diagnostic tools, targeted medications, and other recent advances in the treatment of metastatic NSCLC ...

New blood tests can detect cancer recurrence earlier than traditional scans, potentially giving doctors and patients crucial ...

For the first time in years, small cell lung cancer (SCLC) patients have reason for renewed hope as more treatment options ...

Circulating tumor DNA (ctDNA) testing has the potential to dramatically impact our approach to cancer management. This minimally invasive test, with potential for repeated testing, can track dynamic ...

New targeted therapies allow for the treatment of a disease that is already the fifth leading cause of fatal tumors globally ...

NeoGenomics announced the commercial launch of c-MET CDx for NSCLC, its c-MET companion diagnostic immunohistochemistry (IHC) assay.